GLOBAL BLOOD THERAPEUTICS Stock News

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Baxter International (BAX), Biogen (BIIB) and Emergent Biosolutions

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Baxter International (BAX – Research

In a report released today, Matthew Harrison from Morgan Stanley maintained a Hold rating on Gilead Sciences (GILD), with a price target of $77.00. The

In a report released today, Matthew Harrison from Morgan Stanley maintained a Hold rating on Gilead Sciences ( GILD – Research Report ), with a price target of $77.00 . The company’s shares closed

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abiomed (ABMD), Amgen (AMGN) and Baxter International

Global Blood Therapeutics Inc (NASDAQ:GBT) insider Ted W. Love sold 2,817 shares of the business’s stock in a transaction on Monday, April 27th. The shares were sold at an average price of $80.87, f

Nomura analyst Christopher Marai maintained a Hold rating on BioMarin Pharmaceutical (BMRN) today and set a price target of $77.00. The company's shares

Nomura analyst Christopher Marai maintained a Hold rating on BioMarin Pharmaceutical ( BMRN – Research Report ) today and set a price target of $77.00 . The company’s shares closed last Thursday a

In a report released yesterday, Christopher Marai from Nomura maintained a Buy rating on Sarepta Therapeutics (SRPT), with a price target of $230.00. The

In a report issued on April 28, Christopher Marai from Nomura maintained a Buy rating on Syndax Pharmaceuticals (SNDX), with a price target of $16.00. The

In a report issued on April 28, Christopher Marai from Nomura maintained a Buy rating on Syndax Pharmaceuticals ( SNDX – Research Report ), with a price target of $16.00 . The company’s shares clo

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Universal Health (UHS), Deciphera Pharmaceuticals (DCPH)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Universal Health ( UHS – Research Report ), Deciphera Pharmaceuticals ( DCPH – Research Report ) an

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Humana (HUM), Vertex Pharmaceuticals (VRTX) and Teladoc

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Humana ( HUM – Research Report ), Vertex Pharmaceuticals ( VRTX – Research Report ) and Teladoc ( T